{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:40:47Z","timestamp":1773819647607,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"INFS","award":["92041813"],"award-info":[{"award-number":["92041813"]}]},{"DOI":"10.13039\/501100003121","name":"Ferdowsi University of Mashhad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003121","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.micpath.2017.12.045","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T23:41:33Z","timestamp":1513381293000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen"],"prefix":"10.1016","volume":"115","author":[{"given":"Soheil","family":"Yousefi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tooba","family":"Abbassi-Daloii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hadi","family":"Sekhavati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Tahmoorespur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.micpath.2017.12.045_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas","year":"2006","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2017.12.045_bib2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1517\/13543784.15.10.1141","article-title":"Future trends in human brucellosis treatment","volume":"15","author":"Pappas","year":"2006","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"04","key":"10.1016\/j.micpath.2017.12.045_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1017\/S0950268815002575","article-title":"Systematic review of brucellosis in the Middle East: disease frequency in ruminants and humans and risk factors for human infection","volume":"144","author":"Musallam","year":"2015","journal-title":"Epidemiol. Infect."},{"issue":"24","key":"10.1016\/j.micpath.2017.12.045_bib4","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.vaccine.2015.04.030","article-title":"Recombinant L7\/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB\/c mice against the virulent B. abortus 544 infection","volume":"33","author":"Singh","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2017.12.045_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.molimm.2016.01.001","article-title":"Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+ rP39) against B. abortus 544 and B. melitensis 16M infection in murine model","volume":"71","author":"Tadepalli","year":"2016","journal-title":"Mol. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2017.12.045_bib6","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.ijantimicag.2010.06.013","article-title":"The changing Brucella ecology: novel reservoirs, new threats","volume":"36","author":"Pappas","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"10.1016\/j.micpath.2017.12.045_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molimm.2015.01.009","article-title":"Vaccination with recombinant L7\/L12-truncated Omp31 protein induces protection against Brucella infection in BALB\/c mice","volume":"65","author":"Golshani","year":"2015","journal-title":"Mol. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.micpath.2017.12.045_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.vetmic.2009.06.021","article-title":"Brucellosis: a re-emerging zoonosis","volume":"140","author":"Seleem","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micpath.2017.12.045_bib9","series-title":"Brucellosis in Humans and Animals","author":"Corbel","year":"2006"},{"issue":"10","key":"10.1016\/j.micpath.2017.12.045_bib10","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.micpath.2017.12.045_bib11","first-page":"117","article-title":"Cloning and molecular characterization of Omp31 gene from Brucella melitensis Rev 1 strain","volume":"71","author":"Yousefi","year":"2016","journal-title":"Arch. Razi Inst."},{"issue":"1","key":"10.1016\/j.micpath.2017.12.045_bib12","first-page":"19","article-title":"Immune reactivity of Brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins","volume":"5","author":"Ghasemi","year":"2013","journal-title":"Iran. J. Microbiol."},{"key":"10.1016\/j.micpath.2017.12.045_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetmic.2016.10.027","article-title":"Comparison of potential protection conferred by three immunization strategies (protein\/protein, DNA\/DNA, and DNA\/protein) against Brucella infection using Omp2b in BALB\/c Mice","volume":"197","author":"Golshani","year":"2016","journal-title":"Vet. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2017.12.045_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-1135(02)00110-4","article-title":"Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis","volume":"88","author":"Edmonds","year":"2002","journal-title":"Vet. Microbiol."},{"issue":"27","key":"10.1016\/j.micpath.2017.12.045_bib15","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1016\/j.vaccine.2012.04.036","article-title":"Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis","volume":"30","author":"Gupta","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.micpath.2017.12.045_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2012.02.126","article-title":"Intradermal immunization with outer membrane protein 25 protects Balb\/c mice from virulent B. abortus 544","volume":"51","author":"Goel","year":"2012","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2017.12.045_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.1996.tb08547.x","article-title":"Molecular and immunological characterization of the major outer membrane proteins of Brucella","volume":"145","author":"Cloeckaert","year":"1996","journal-title":"FEMS Microbiol. Lett."},{"issue":"1","key":"10.1016\/j.micpath.2017.12.045_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1099\/00222615-47-1-39","article-title":"Evaluation of immunogenicity and protective activity in BALB\/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli","volume":"47","author":"Bowden","year":"1998","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2017.12.045_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2006.07.046","article-title":"The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes","volume":"25","author":"Commander","year":"2007","journal-title":"Vaccine"},{"issue":"37\u201338","key":"10.1016\/j.micpath.2017.12.045_bib20","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.micpath.2017.12.045_bib21","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1128\/IAI.69.8.4823-4830.2001","article-title":"Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages","volume":"69","author":"Jubier-Maurin","year":"2001","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.micpath.2017.12.045_bib22","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.4049\/jimmunol.1300999","article-title":"Immunization with a chimera consisting of the B Subunit of shiga toxin type 2 and Brucella lumazine synthase confers total protection against shiga toxins in mice","volume":"191","author":"Mejias","year":"2013","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2017.12.045_bib23","doi-asserted-by":"crossref","first-page":"e0126827","DOI":"10.1371\/journal.pone.0126827","article-title":"Brucella spp. Lumazine synthase induces a TLR4-mediated protective response against B16 melanoma in mice","volume":"10","author":"Rossi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2017.12.045_bib24","series-title":"Molecular Cloning : a Laboratory Manual","author":"Sambrook","year":"2001"},{"issue":"1","key":"10.1016\/j.micpath.2017.12.045_bib25","first-page":"35","article-title":"In silico analysis of Omp25 and BLS Brucella melitensis antigens for designing subunit vaccine","volume":"71","author":"Tahmoorespur","year":"2016","journal-title":"Arch. Razi Inst."},{"issue":"5","key":"10.1016\/j.micpath.2017.12.045_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4103\/1735-5362.192493","article-title":"Cloning, expression and molecular analysis of Iranian Brucella melitensis Omp25 gene for designing a subunit vaccine","volume":"11","author":"Yousefi","year":"2016","journal-title":"Res. Pharmaceut. Sci."},{"issue":"6","key":"10.1016\/j.micpath.2017.12.045_bib27","first-page":"681","article-title":"SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments","volume":"11","author":"Geourjon","year":"1995","journal-title":"CABIOS\/Comput. Appl. Biosci."},{"key":"10.1016\/j.micpath.2017.12.045_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.micpath.2017.12.045_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"issue":"10","key":"10.1016\/j.micpath.2017.12.045_bib30","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2017.12.045_bib31","unstructured":"S. Yousefi, T. Abbassi-Daloii, M. Tahmoorespur, M. H. Sekhavati and (Submitted) (Submitted). \"Nanoparticle adjuvant or conventional adjuvant: which one improves immunogenicity against Brucella melitensis infection?\"."},{"issue":"42","key":"10.1016\/j.micpath.2017.12.045_bib32","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.vaccine.2015.09.013","article-title":"Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection","volume":"33","author":"Ghasemi","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.micpath.2017.12.045_bib33","first-page":"499","article-title":"Cloning, molecular analysis and epitopics prediction of a new chaperone GroEL Brucella melitensis antigen","volume":"18","author":"Sekhavati","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"4","key":"10.1016\/j.micpath.2017.12.045_bib34","first-page":"853","article-title":"Dual promoter vector construction for simultaneous gene expression using spliced overlap extension by polymerase chain reaction (SOE-PCR) technique","volume":"5","author":"Sekhavati","year":"2015","journal-title":"Iran. J. Appl. Anim. Sci."},{"issue":"4","key":"10.1016\/j.micpath.2017.12.045_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.18869\/modares.iem.2.4.32","article-title":"Vaccines and vaccine candidates against brucellosis","volume":"2","author":"Mansoori","year":"2016","journal-title":"Infect. Epidemiol. Med."},{"issue":"10","key":"10.1016\/j.micpath.2017.12.045_bib36","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1128\/IAI.69.10.6541-6544.2001","article-title":"Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection","volume":"69","author":"Pasquali","year":"2001","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.micpath.2017.12.045_bib37","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect. Immun."},{"issue":"51","key":"10.1016\/j.micpath.2017.12.045_bib38","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1016\/j.vaccine.2013.07.041","article-title":"The vaccine candidate BLSOmp31 protects mice against Brucella canis infection","volume":"31","author":"Clausse","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.micpath.2017.12.045_bib39","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2017.12.045_bib40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect. Immun."},{"issue":"45","key":"10.1016\/j.micpath.2017.12.045_bib41","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1016\/j.vaccine.2014.08.073","article-title":"Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7\/L12 or Omp16 proteins: evaluation of protection in pregnant heifers","volume":"32","author":"Tabynov","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.micpath.2017.12.045_bib42","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1128\/IAI.73.11.7297-7303.2005","article-title":"Selection of protective epitopes for Brucella melitensis by DNA vaccination","volume":"73","author":"Yang","year":"2005","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.micpath.2017.12.045_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1574-695X.2010.00758.x","article-title":"Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection","volume":"61","author":"Yang","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1\u20134","key":"10.1016\/j.micpath.2017.12.045_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-1135(02)00211-0","article-title":"Major outer membrane proteins of Brucella spp.: past, present and future","volume":"90","author":"Cloeckaert","year":"2002","journal-title":"Vet. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2017.12.045_bib45","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.micpath.2017.12.045_bib46","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.micpath.2017.12.045_bib47","doi-asserted-by":"crossref","first-page":"e45705","DOI":"10.1371\/journal.pone.0045705","article-title":"A polymeric protein induces specific cytotoxicity in a TLR4 dependent manner in the absence of adjuvants","volume":"7","author":"Berguer","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.micpath.2017.12.045_bib48","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/CVI.00472-06","article-title":"Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting","volume":"14","author":"Cassataro","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2017.12.045_bib49","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.micinf.2005.12.006","article-title":"Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity","volume":"8","author":"Rosas","year":"2006","journal-title":"Microb. Infect."},{"issue":"1","key":"10.1016\/j.micpath.2017.12.045_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mimet.2006.12.015","article-title":"Evaluation of Brucella MLVA typing for human brucellosis","volume":"69","author":"Al Dahouk","year":"2007","journal-title":"J. Microbiol. Meth."},{"issue":"2","key":"10.1016\/j.micpath.2017.12.045_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-1135(02)00101-3","article-title":"Mice immune responses to Brucella abortus heat shock proteins. Use of baculovirus recombinant-expressing whole insect cells, purified Brucella abortus recombinant proteins, and a vaccinia virus recombinant as immunogens","volume":"88","author":"Bae","year":"2002","journal-title":"Vet. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2017.12.045_bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-1135(00)00231-5","article-title":"Humoral immune response of BALB\/c mice to a vaccinia virus recombinant expressing Brucella abortus GroEL does not correlate with protection against a B. abortus challenge","volume":"76","author":"Baloglu","year":"2000","journal-title":"Vet. Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2017.12.045_bib53","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1128\/IAI.64.10.4396-4400.1996","article-title":"Immunological response to the Brucella abortus GroEL homolog","volume":"64","author":"Lin","year":"1996","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.micpath.2017.12.045_bib54","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/CVI.00527-14","article-title":"Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB\/c mice","volume":"21","author":"Clausse","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2017.12.045_bib55","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/IAI.61.1.124-134.1993","article-title":"Effects of cytokines on intracellular growth of Brucella abortus","volume":"61","author":"Jiang","year":"1993","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.micpath.2017.12.045_bib56","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4049\/jimmunol.143.10.3330","article-title":"Temporal development of protective cell-mediated and humoral immunity in BALB\/c mice infected with Brucella abortus","volume":"143","author":"Araya","year":"1989","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.micpath.2017.12.045_bib57","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/eji.1830250922","article-title":"CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice","volume":"25","author":"Oliveira","year":"1995","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.micpath.2017.12.045_bib58","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1128\/IAI.69.9.5417-5422.2001","article-title":"Ontogeny of Th1 memory responses against a Brucella abortus conjugate","volume":"69","author":"Scharf","year":"2001","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.micpath.2017.12.045_bib59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/IAI.63.3.969-975.1995","article-title":"Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts","volume":"63","author":"Zhan","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.12.045_bib60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0378-1135(02)00222-5","article-title":"Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection","volume":"90","author":"Baldwin","year":"2002","journal-title":"Vet. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2017.12.045_bib61","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.161.3.1447","article-title":"Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors","volume":"161","author":"Zhan","year":"1998","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.micpath.2017.12.045_bib62","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1128\/IAI.64.7.2782-2786.1996","article-title":"Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms","volume":"64","author":"Zhan","year":"1996","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2017.12.045_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1286-4579(00)01350-2","article-title":"Immunity and protection against Brucella abortus","volume":"3","author":"Golding","year":"2001","journal-title":"Microb. Infect."},{"issue":"3","key":"10.1016\/j.micpath.2017.12.045_bib64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.rvsc.2006.07.014","article-title":"Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis 16M","volume":"82","author":"Gupta","year":"2007","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.micpath.2017.12.045_bib65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.06.040188.001343","article-title":"Structure and function of human and murine receptors for IgG","volume":"6","author":"Unkeless","year":"1988","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.micpath.2017.12.045_bib66","doi-asserted-by":"crossref","first-page":"e82508","DOI":"10.1371\/journal.pone.0082508","article-title":"Vivo identification and characterization of CD4+ cytotoxic T cells induced by virulent Brucella abortus infection","volume":"8","author":"Martirosyan","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.micpath.2017.12.045_bib67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1286-4579(02)00075-8","article-title":"The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB\/c mice","volume":"5","author":"Estein","year":"2003","journal-title":"Microb. Infect."},{"issue":"1\u20132","key":"10.1016\/j.micpath.2017.12.045_bib68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vetimm.2013.04.003","article-title":"Immune response and serum bactericidal activity against Brucella ovis elicited using a short immunization schedule with the polymeric antigen BLSOmp31 in rams","volume":"154","author":"Diaz","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.micpath.2017.12.045_bib69","article-title":"Impact of heat shock protein 60KD in combination with outer membrane proteins on immune response against Brucella melitensis","author":"Abbassi-Daloii","year":"2017","journal-title":"APMIS"},{"issue":"7","key":"10.1016\/j.micpath.2017.12.045_bib70","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.vaccine.2009.12.012","article-title":"Protection of BALB\/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein","volume":"28","author":"Al-Mariri","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.micpath.2017.12.045_bib71","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/IAI.05080-11","article-title":"Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses","volume":"79","author":"Clapp","year":"2011","journal-title":"Infect. Immun."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401017312767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401017312767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:43:19Z","timestamp":1693338199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401017312767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":71,"alternative-id":["S0882401017312767"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2017.12.045","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2017.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}